Improving Access to the Treatment of Anxiety and Depression Among Young Adults
Improving Access to Treatment of Anxiety and Depression in Young Adults Using Transdignostic iCBT: Feasibility of a Translated Version of an Empirically Supported Program
Sponsor: Horizon Health Network
A NA clinical study on Agoraphobia and Generalized Anxiety Disorder, this trial is completed. The trial is conducted by Horizon Health Network and has accumulated 8 data snapshots since 2017. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2022 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Jul 2022 [monthly]
Unknown Status NA
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Nov 2018 — Nov 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting NA
Status: Not Yet Recruiting → Active Not Recruiting
-
Jun 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Horizon Health Network
- Macquarie University, Australia
- MindCare Inc.
- Royal Bank of Canada
- Universite de Moncton
- University of Regina
For direct contact, visit the study record on ClinicalTrials.gov .